TABLE 3

Respiratory Support Modality and Associated Clinical and Demographic Data

NonintubatedIntubated
NC/NRBNPPVIMV-OSHIMV-PCH
HFNCCPAP/BiPAP
Total, n (%)184 (70)26 (10)37 (14)11 (4)4 (2)
Age, y, median (range)6 (2–17)6 (2–14)9 (2–15)a6 (2–13)4 (3–7)
PICU LOS, d, median (range)1.2 (0.2–11.4)3.6 (0.6–8.5)a3.6 (1.0–9.0)a2.6 (0.4–4.5)12.7 (10.9–14.8)b
 PICU LOS <24 h, n (%)62 (34)2 (8)02 (18)0
 PICU LOS 1–3 d, n (%)97 (53)8 (31)14 (38)5 (45)0
 PICU LOS >3 d, n (%)25 (14)16 (62)23 (62)4 (36)4 (100)
CXR and/or admission, median (range)1.0 (0–1.0)2.0 (1.0–4.0)a1.0 (1.0–4.0)3.0 (1.0–5.0)15 (11.3–18.0)b
Laboratories and/or admission, median (range)
 Blood gas panel1.0 (0–1.0)1.5 (1.0–3.3)a2.0 (1.0–4.0)a4.0 (2.0–13.0)27.0 (5.3–40.4)
 CBC0 (0–0)1 (0–1.0)a1.0 (0–1.0)a1 (0–3.0)2.5 (1.0–10.8)
 Chemistry panel1.0 (0–1.0)1.5 (1.0–3.0)a1.0 (1.0–2.0)a2.0 (1.0–9.0)13 (10.0–22.0)b
  • a Comparison groups include only those who never received invasive ventilation; P < .0125 for pairwise comparisons with the NC/NRB group.

  • b Comparisons are among only those receiving invasive mechanical ventilation.